BOS Asset Management LLC Acquires 192 Shares of HCA Healthcare, Inc. $HCA

BOS Asset Management LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,760 shares of the company’s stock after buying an additional 192 shares during the period. BOS Asset Management LLC’s holdings in HCA Healthcare were worth $954,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Avantax Advisory Services Inc. boosted its position in shares of HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after buying an additional 32 shares during the period. Glenview Trust co boosted its position in shares of HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after buying an additional 32 shares during the period. Horizon Investments LLC boosted its position in HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares during the last quarter. Catalyst Financial Partners LLC boosted its position in HCA Healthcare by 4.3% during the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company’s stock valued at $301,000 after purchasing an additional 36 shares during the last quarter. Finally, RWA Wealth Partners LLC boosted its position in HCA Healthcare by 2.0% during the first quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company’s stock valued at $658,000 after purchasing an additional 37 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the subject of several recent research reports. Truist Financial increased their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a research report on Wednesday, July 16th. Barclays dropped their price objective on HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating on the stock in a research note on Monday, July 28th. Royal Bank Of Canada dropped their price objective on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research note on Monday, July 28th. Stephens upgraded HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $403.17.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $394.00 on Thursday. The business’s 50 day moving average is $381.63 and its 200-day moving average is $361.70. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $420.98. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The firm has a market cap of $92.19 billion, a P/E ratio of 16.56, a price-to-earnings-growth ratio of 1.30 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is currently 12.11%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.